prostaglandin F

The following medications are analogs of prostaglandin F:

Latanoprost is a prostaglandin F receptor agonist.

It is a synthetic prostaglandin analog (or more specifically, an analog of prostaglandin F) that works by increasing the outflow of aqueous fluid from the eyes.

Non-steroidal anti-inflammatory drugs, ionic cholegraphic contrast media, and intravenous preparations of hydrocortisone, benzylpenicillin, and sulphonamides release prostaglandin F 2 a from serum proteins.

However, bimatoprost is chemically analogous to prostaglandin F (PGF), a compound which is known to reduce fat by inhibition of adipocyte differentiation and survival.

In the new procedure, reported by obstetricians at the University of Goteborg in Sweden, a small amount of prostaglandin F is injected directly above the implanted embryo.

Prostaglandin F (PGF in prostanoid nomenclature), pharmaceutically termed dinoprost (INN), is a naturally occurring prostaglandin used in medicine to induce labor and as an abortifacient.

The first total syntheses of prostaglandin F and prostaglandin E were reported by E. J. Corey in 1969, an achievement for which he was awarded the Japan Prize in 1989.

Prostaglandin F receptor (FP) is a receptor for Prostaglandin F. It is encoded by the gene PTGFR.

In most species, the luteolytic cascade, starting with loss of progesterone production and followed by tissue regression ( i.e. apoptosis), is initiated by prostaglandin F 2α (PGF 2α ) in vivo [ 4 ] .

The aldo-keto reductase family is a family of enzymes that includes a number of related monomeric NADPH-dependent oxidoreductases, such as aldehyde reductase, aldose reductase, prostaglandin F synthase, xylose reductase, rho crystallin, and many others.